OZEM vs WDNA: Holdings Overlap & Returns

Over the year to Nov 13, 2026, OZEM returned +0.7% to WDNA's +43.3%; 13% of their weight is in the same names.

Return gap
+42.6 pts1 year to Nov 13, 2026: WDNA ahead, total return
Fee gap
0.14 ptsA year: OZEM 0.59%, WDNA 0.45%, per filings dated Apr 30, 2026 and Oct 28, 2026
Overlap
13%Share of the two books held in common, holdings dated Nov 13, 2026 and Jun 30, 2026
Net flow
–Needs daily flows for both funds
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
OZEM and WDNA · 1 year

Growth of 100

OZEM +0.7%WDNA +43.3%
Growth of 100 in OZEM and WDNA over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. OZEM ends at 100.7 (+0.7%), WDNA at 143.3 (+43.3%).

OZEM +0.7%, WDNA +43.3%: WDNA +42.6 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

OZEM flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in OZEM for 10 years at 0.59% a year costs about $972 in fees and lost growth; WDNA at 0.45% would cost $746. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

OZEM · 1 year to Nov 13, 202670% of its weight is outside the S&P 500
70% of its weight is outside the S&P 50030% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.30%70%in the S&P 500of its weight outside the S&P 500active share 98% · top ten 72% of the fund · 21 holdings as published by its issuer for Nov 13, 2026 · Nasdaq-100: 4% in70% of its weight is outside the S&P 50030% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.30%70%inoutside the S&P 500active share 98% · Nasdaq-100: 4% in

30% of OZEM's weight is in S&P 500 companies and 70% is outside the index. Holdings as of Nov 13, 2026.

WDNA · 1 year to Nov 13, 202674% of its weight is outside the S&P 500
74% of its weight is outside the S&P 50026% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.26%74%in the S&P 500of its weight outside the S&P 500active share 95% · top ten 31% of the fund · 80 holdings as filed for Jun 30, 2026 · Nasdaq-100: 5% in74% of its weight is outside the S&P 50026% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.26%74%inoutside the S&P 500active share 95% · Nasdaq-100: 5% in

26% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.

Key numbers

OZEM in the S&P 500
30.4%
WDNA in the S&P 500
25.9%
OZEM total return, 1 year
+0.7%
WDNA total return, 1 year
+43.3%

WDNA costs 0.14 points a year less; their one-year returns differ by 42.6 points.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+0.7%+43.3%
Below its all-time high15.1%, high on Jan 26, 202613.9%, high on Sep 2, 2021
What it tracksHealthcare innovation and GLP-1Healthcare innovation and GLP-1
Expense ratio0.59%0.45%
Net assets, OZEM as of Nov 13, 2026 and WDNA as of Jun 30, 2026$57m$2.7m
Holdings in common13%

The numbers behind it

Net assets: $57m on Nov 13, 2026 for Roundhill GLP-1 & Weight Loss ETF, and $2.7m on Jun 30, 2026 for WisdomTree BioRevolution Fund.

Holdings in common uses holdings dated Jun 30, 2026 and Nov 13, 2026.

What they share

By the books each fund has filed, OZEM and WDNA hold 13% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 13, 2026.

0half (50%)100%

half

13% in common

Held in common

Show all 7 holdings
Eli Lilly & Co20.30%4.08%
Structure Therapeutics Inc2.96%2.12%
AstraZeneca PLC3.22%1.83%
Amgen Inc2.99%1.54%
Gilead Sciences Inc1.39%1.51%
Pfizer Inc5.69%1.34%
Viking Therapeutics Inc3.94%0.93%

Only in OZEM

Show all 8 holdings
Novo Nordisk A/S10.86%
Hanmi Pharm Co Ltd6.97%
Chugai Pharmaceutical Co Ltd6.82%
Kailera Therapeutics Inc4.89%
CSPC Pharmaceutical Group Ltd4.56%
Jiangsu Hengrui Pharmaceuticals Co Ltd4.16%
Hansoh Pharmaceutical Group Co Ltd3.77%
Ascletis Pharma Inc3.36%

Only in WDNA

Show all 8 holdings
TWIST BIOSCIENCE CORP5.95%
MODERNA INC4.14%
JOHNSON & JOHNSON2.97%
UNITED THERAPEUTICS CORP2.45%
NATERA INC2.32%
TEMPUS AI INC2.28%
IMMUNOME INC2.26%
STOKE THERAPEUTICS INC2.09%

Side by side

Open the table
FundRoundhill GLP-1 & Weight Loss ETF · Holds 21 stocks in healthcare innovation and GLP-1, 30% of its weight in S&P 500 companiesWisdomTree BioRevolution Fund · Holds 80 stocks in healthcare innovation and GLP-1, 26% of its weight in S&P 500 companies
IssuerRoundhillWisdomTree
ThemeHealthcare innovation and GLP-1Healthcare innovation and GLP-1
In the S&P 50030.4%25.9%
Active share vs the S&P 50097.8%95.3%
In the Nasdaq-1004.4%5.2%
Holdings2180
Top ten, share of the fund72.0%30.7%
Expense ratio0.59%0.45%
Fee for the differing part0.60%0.47%
Total return, 1 year+0.7%+43.3%
vs its benchmarknot measurednot measured
Below its high−15.1%−13.9%
Net assets, OZEM as of Nov 13, 2026 and WDNA as of Jun 30, 2026$57m$2.7m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months−4.9%+6.8%
6 months+1.8%+30.6%
1 year+0.7%+43.3%
3 years–+62.5%
Since launch (Not the same days: OZEM May 2024 · WDNA Jun 2021)+25.6%−3.7%

– means no data for this window.

About OZEM

By weight, 30% of OZEM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 72% of the fund across 21 positions, as published by its issuer for Nov 13, 2026.

More

Over the year to Nov 13, 2026 the fund returned +0.7% with distributions reinvested. It sits 15.1% below its all-time high of Jan 26, 2026.

About WDNA

By weight, 26% of WDNA's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 31% of the fund across 80 positions, as filed for Jun 30, 2026.

More

Over the year to Nov 13, 2026 the fund returned +43.3% with distributions reinvested. It sits 13.9% below its all-time high of Sep 2, 2021.

13% of the two portfolios are the same securities at the same weight.

Questions people ask

Do OZEM and WDNA hold the same stocks?

By their latest filings, 13% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, OZEM or WDNA?

OZEM has 30% of its weight in S&P 500 names and WDNA has 26%, so OZEM differs more from the index.

Which is cheaper, OZEM or WDNA?

OZEM charges 0.59% a year and WDNA charges 0.45%, so WDNA is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, OZEM against WDNA, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ozem-vs-wdna

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.